| Previous Close | Open | Close* |
|---|---|---|
| 3.1 | 3.11 | 3.13 |
| Market Cap | Dividend Yield (Annualized) |
|---|---|
| AUD 631.74M | 16.50% |
| Day Range |
|---|
| 3.1L 3.19 H |
| 52 WEEK HIGH LOW |
|---|
| 2.865L 5.88 H |
| Last Trade | 3.13 |
|---|---|
| Change% | 0.9677 |
| 52 W H/L | 5.880/2.865 |
| EBITDA | 362.335M |
| NPAT After Abnormal Items | 178.244M |
| Equity | 232.557M |
| ROE% | 79.86% |
| Total Liabilities | 395.485M |
| Total Revenue | 997.165M |
| Cash and Cash Equivalents | 26.372M |
| Share price | 3.13 |
|---|---|
| Market Cap | 631.74M |
| Price/Gross Cash Flow | 3.11 |
| Dividend Yield Excluding Special | 11.55% |
| Ending Shares | 201.834M |
| 52-Week Range | 5.880-2.865 |
| Gross DPS (AUD) | 0.7571 |
| Gross Dividend Yield (Annualized) | 16.50% |
| Earnings Yield | 28.540 |
| Net Tangible Asset (NTA) | 0.33 |
| P/E ratio | 3.504 |
| Sector P/E | -- |
| EPS | 88.46 |
| EV/EBITDA | 3.06 |
| Net Profit Margin (%) | 18.76% |
| Gross Cash Flows Per Share | 1.48 |
| Net Gearing | 101.48% |
| Sales Per Share | 4.91 |
| Book Value Per Share | 1.15 |
Australian Clinical Labs Limited (ACL) is a private provider of pathology services in Australia. ACL's mission is to combine talented people, medical and scientific leadership, with innovative thinking and technologies to empower decision making that saves and improves patients' lives. It is servicing over 90 private and public hospitals.
| Ex-Date | Net Dividend | Frank Flag | Period End Date | Type | Payable |
|---|
| Event Type | Event Date | Event Year |
|---|---|---|
| Report (Interim) | 2023-02-23 | 2023 |
| Report (Annual) | 2022-09-23 | 2022 |
| Report (Prelim) | 2022-08-25 | 2022 |
| Div Pay Date | 2022-04-21 | 2022 |